QNRX
Quoin Pharmaceuticals, Ltd.
stockNASDAQADR
At CloseOct 12, 2026 3:59:39 PM EDT
4.42USD+1.376%(+0.06)26,328
Pre-marketOct 13, 2026 9:20:30 AM EDT
4.49USD+2.982%(+0.13)
After-hoursOct 12, 2026 4:49:30 PM EDT
4.36USD-1.357%(-0.06)
Loading…
Loading…
8.33M
Healthcare
Biotechnology
HQ
Ashburn, VA, USA
Previous Close
$4.36
Beta
0.75
52-Week High
$23.50 2025-11-25
52-Week Low
$3.25 2026-06-23
SMA 50
$5.69
SMA 200
$6.69
Avg. Vol 10D
54,126
Avg. Vol 30D
100,575
Avg. Vol 90D
542,857
Relative Vol
0.24
2.01M
1.44M
71.77%
65,473
4.54%
1.38
61%/39%
58.07%
38.23%
117.4800%
20,000
11,726
20,881
182,046
Nov 5, 2026 (23d)
Apr 9, 2025 · 1-for-35 (reverse)
Oct 12, 2026
BTIG initiates Quoin Pharmaceuticals stock with buy rating · 
Investing.com
Oct 6, 2026
Sep 22, 2026
QNRX Profile
cellect biotechnology was founded in 2011 with a mission to become a global leader in the next generation of cellular therapies by developing innovative solutions for immune system regeneration. achieving higher selectivity, greater specificity and decreased toxicity, cellect envisions its products becoming an integral and essential part of bone marrow transplantation (bmt), as well as integrated into many aspects of regenerative medicine.
QNRX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 4.72 | 2026-10-06 | -12.08% | 1.239 |
| 1M | 6.88 | 2026-09-14 | -39.68% | 3.266 |
| 3M | 4.23 | 2026-07-13 | -1.89% | 1.332 |
| 6M | 5.92 | 2026-04-13 | -29.90% | 1.046 |
| 1Y | 14.86 | 2025-10-13 | -72.07% | 0.754 |
| 2Y | 17.85 | 2024-10-14 | -76.75% | — |
| 5Y | 1,055,250.00 | 2021-10-13 | -100.00% | -0.181 |
QNRX Stock Summary
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) stock price today is $4.15, and today's volume is 24,446. QNRX is down 4.817% today. The 30 day average volume is 100,575. QNRX market cap is $8.33M with 2.01M shares outstanding.